Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1996 Mar 30;312(7034):823–826.

Morphine in cancer pain: modes of administration. Expert Working Group of the European Association for Palliative Care.

PMCID: PMC2350688  PMID: 8608293

Full text

PDF
823

Images in this article

824p824-a
on p.824

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chrubasik J., Wüst H., Friedrich G., Geller E. Absorption and bioavailability of nebulized morphine. Br J Anaesth. 1988 Aug;61(2):228–230. doi: 10.1093/bja/61.2.228. [DOI] [PubMed] [Google Scholar]
  2. De Conno F., Ripamonti C., Saita L., MacEachern T., Hanson J., Bruera E. Role of rectal route in treating cancer pain: a randomized crossover clinical trial of oral versus rectal morphine administration in opioid-naive cancer patients with pain. J Clin Oncol. 1995 Apr;13(4):1004–1008. doi: 10.1200/JCO.1995.13.4.1004. [DOI] [PubMed] [Google Scholar]
  3. Dover S. B. Syringe driver in terminal care. Br Med J (Clin Res Ed) 1987 Feb 28;294(6571):553–555. doi: 10.1136/bmj.294.6571.553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Finn J. W., Walsh T. D., MacDonald N., Bruera E., Krebs L. U., Shepard K. V. Placebo-blinded study of morphine sulfate sustained-release tablets and immediate-release morphine sulfate solution in outpatients with chronic pain due to advanced cancer. J Clin Oncol. 1993 May;11(5):967–972. doi: 10.1200/JCO.1993.11.5.967. [DOI] [PubMed] [Google Scholar]
  5. Hanks G. W. Antiemetics for terminal cancer patients. Lancet. 1982 Jun 19;1(8286):1410–1410. doi: 10.1016/s0140-6736(82)92522-3. [DOI] [PubMed] [Google Scholar]
  6. Hanks G. W. Controlled-release morphine (MST Contin) in advanced cancer. The European experience. Cancer. 1989 Jun 1;63(11 Suppl):2378–2382. doi: 10.1002/1097-0142(19890601)63:11<2378::aid-cncr2820631150>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  7. Hanks G. W., Hoskin P. J., Aherne G. W., Turner P., Poulain P. Explanation for potency of repeated oral doses of morphine? Lancet. 1987 Sep 26;2(8561):723–725. doi: 10.1016/s0140-6736(87)91083-x. [DOI] [PubMed] [Google Scholar]
  8. Hogan Q., Haddox J. D., Abram S., Weissman D., Taylor M. L., Janjan N. Epidural opiates and local anesthetics for the management of cancer pain. Pain. 1991 Sep;46(3):271–279. doi: 10.1016/0304-3959(91)90110-J. [DOI] [PubMed] [Google Scholar]
  9. Kaiko R. F. The therapeutic equivalence of i.m. and p.o. administration of morphine--1:3 or 1:6? J Palliat Care. 1988 May;4(1-2):64–66. [PubMed] [Google Scholar]
  10. Kalso E., Vainio A. Morphine and oxycodone hydrochloride in the management of cancer pain. Clin Pharmacol Ther. 1990 May;47(5):639–646. doi: 10.1038/clpt.1990.85. [DOI] [PubMed] [Google Scholar]
  11. Leslie S. T., Rhodes A., Black F. M. Controlled release morphine sulphate tablets--a study in normal volunteers. Br J Clin Pharmacol. 1980 May;9(5):531–534. doi: 10.1111/j.1365-2125.1980.tb05858.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. McQuay H. J., Moore R. A., Hand C. W., Sear J. W. Potency of oral morphine. Lancet. 1987 Dec 19;2(8573):1458–1459. doi: 10.1016/s0140-6736(87)91153-6. [DOI] [PubMed] [Google Scholar]
  13. McQuay H. J. The logic of alternative routes. J Pain Symptom Manage. 1990 Apr;5(2):75–77. doi: 10.1016/s0885-3924(05)80019-3. [DOI] [PubMed] [Google Scholar]
  14. Plummer J. L., Cherry D. A., Cousins M. J., Gourlay G. K., Onley M. M., Evans K. H. Long-term spinal administration of morphine in cancer and non-cancer pain: a retrospective study. Pain. 1991 Mar;44(3):215–220. doi: 10.1016/0304-3959(91)90088-F. [DOI] [PubMed] [Google Scholar]
  15. Portenoy R. K., Coyle N. Controversies in the long-term management of analgesic therapy in patients with advanced cancer. J Pain Symptom Manage. 1990 Oct;5(5):307–319. doi: 10.1016/0885-3924(90)90047-n. [DOI] [PubMed] [Google Scholar]
  16. Poulain P., Hoskin P. J., Hanks G. W., A-Omar O., Walker V. A., Johnston A., Turner P., Aherne G. W. Relative bioavailability of controlled release morphine tablets (MST continus) in cancer patients. Br J Anaesth. 1988 Nov;61(5):569–574. doi: 10.1093/bja/61.5.569. [DOI] [PubMed] [Google Scholar]
  17. Ripamonti C., Bruera E. Rectal, buccal, and sublingual narcotics for the management of cancer pain. J Palliat Care. 1991 Spring;7(1):30–35. [PubMed] [Google Scholar]
  18. Schug S. A., Zech D., Grond S., Jung H., Meuser T., Stobbe B. A long-term survey of morphine in cancer pain patients. J Pain Symptom Manage. 1992 Jul;7(5):259–266. doi: 10.1016/0885-3924(92)90059-q. [DOI] [PubMed] [Google Scholar]
  19. Sjöberg M., Appelgren L., Einarsson S., Hultman E., Linder L. E., Nitescu P., Curelaru I. Long-term intrathecal morphine and bupivacaine in "refractory" cancer pain. I. Results from the first series of 52 patients. Acta Anaesthesiol Scand. 1991 Jan;35(1):30–43. doi: 10.1111/j.1399-6576.1991.tb03237.x. [DOI] [PubMed] [Google Scholar]
  20. Säwe J., Dahlström B., Rane A. Steady-state kinetics and analgesic effect of oral morphine in cancer patients. Eur J Clin Pharmacol. 1983;24(4):537–542. doi: 10.1007/BF00609900. [DOI] [PubMed] [Google Scholar]
  21. Säwe J. High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment. Clin Pharmacokinet. 1986 Mar-Apr;11(2):87–106. doi: 10.2165/00003088-198611020-00001. [DOI] [PubMed] [Google Scholar]
  22. Twycross R. G. Control of pain. J R Coll Physicians Lond. 1984 Jan;18(1):32–39. [PMC free article] [PubMed] [Google Scholar]
  23. Twycross R. G. Opioid analgesics in cancer pain: current practice and controversies. Cancer Surv. 1988;7(1):29–53. [PubMed] [Google Scholar]
  24. Twycross R. G. The therapeutic equivalence of oral and subcutaneous/intramuscular morphine sulphate in cancer patients. J Palliat Care. 1988 May;4(1-2):67–68. [PubMed] [Google Scholar]
  25. Vainio A., Ollila J., Matikainen E., Rosenberg P., Kalso E. Driving ability in cancer patients receiving long-term morphine analgesia. Lancet. 1995 Sep 9;346(8976):667–670. doi: 10.1016/s0140-6736(95)92281-4. [DOI] [PubMed] [Google Scholar]
  26. Zech D. F., Grond S. U., Lynch J., Dauer H. G., Stollenwerk B., Lehmann K. A. Transdermal fentanyl and initial dose-finding with patient-controlled analgesia in cancer pain. A pilot study with 20 terminally ill cancer patients. Pain. 1992 Sep;50(3):293–301. doi: 10.1016/0304-3959(92)90034-9. [DOI] [PubMed] [Google Scholar]
  27. Zech D. F., Grond S., Lynch J., Hertel D., Lehmann K. A. Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study. Pain. 1995 Oct;63(1):65–76. doi: 10.1016/0304-3959(95)00017-M. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES